On 12th July, Qingdao Boyit Biomaterials Co., Ltd. and MH.Biotech(Beijing)Co.Ltd. signed a strategic cooperation agreement.The co-operation will take the ‘Hemostatic Wound Healing Gauze’ product as the base point, and jointly promote the incubation of more high-quality pet health products, integrating the upstream and downstream resources such as raw material procurement, manufacturing, sales channels and so on.
As a leader in the chitosan industry, Boyit has established a good reputation in the market by virtue of its excellent modification technology strength and innovation ability. Kido Bio, with its rich resources and extensive market channels, has demonstrated strong market competitiveness in the pet medical market. This strategic co-operation will realise the complementary advantages, resource sharing and synergy between the two parties, and jointly develop a broader market space.
Bao Shangcheng, head of Boyt Pet Channel, and Shen Quan, chairman of Kido Technology, solemnly signed the co-operation agreement on behalf of both companies and exchanged documents.
At the signing ceremony, Mr Nie Renke, Chairman of Boyit, warmly welcomed the arrival of the Kido team and said, ‘This cooperation is an important milestone in the development history of both of us. Boyit will provide more stable, better quality products with core competitiveness, and give full play to our advantages in R&D, preparation and production. We believe that by integrating the advantageous resources of both parties, we will be able to provide our customers with better quality and more comprehensive solutions and promote the innovation and development of the pet medical industry.’
Mr Shen Quan, Chairman of MuHu Technology, is also full of confidence in this cooperation, he said, ‘Boyt's achievements in technology development and innovation are obvious to all, and cooperating with such an excellent company will bring us new ideas and motivation. We look forward to working together to create more value and achieve mutual benefits in our future cooperation.’
The strategic co-operation involves a number of projects in technology research and development, market expansion, customer service and so on. The two sides will work closely together to optimise the professional team, carry out in-depth cooperation projects, jointly overcome industry challenges, and improve the quality of products and services to meet the changing needs of the market.
With the successful conclusion of the signing ceremony, the co-operation journey between Boytek Bio and Kido Technology has officially set sail. It is believed that under the joint efforts of both parties, they will stand out in the fierce market competition, create more brilliant performance and make greater contribution to the development of the industry!
Founded in 2006, Qingdao Boyit Biomaterials Co., Ltd. is a national high-tech enterprise specialising in the R&D, production and sales of marine biomedical materials. The company takes marine biomedical materials as the leading company, and focuses on the development of haemostatic materials, trauma repair materials, ophthalmic implantation materials and tissue engineering scaffold materials. The company has achieved outstanding results in the innovation of chitin and chitosan-based medical materials.Boyit is a national speciality, speciality and new ‘small giant’, the National Biomedical Materials Engineering and Technology Research Centre of Marine Biomedical Materials Joint Innovation Research Base, the National Intellectual Property Advantageous Enterprises, Shandong Province Chitosan-Based Marine Biomedical Materials Engineering and Technology Co-innovation Centre, Qingdao Chitosan-Based Marine Biomedical Materials Manufacturing Technology Innovation Centre, Qingdao Marine Biomedical Materials Engineering Research Centre, Qingdao Postdoctoral Research Station, Qingdao Marine Biomedical Materials Expert Workstation. With the qualification of three kinds of medical device production licence, 12000 square meters of GMP production workshop, quality management system through ISO13485, ISO 9001, EN ISO13485 (EU) certification, is the Qingdao medical device production supervision and practice base, is the chitosan medical material national industry standard YY/T1699-2020 ‘Tissue Engineering Medical Device Products Chitosan’, [6-7] YY/T 0953-2020 ‘Carboxymethyl Chitosan for Medical Use’.
MuHu Biotechnology (Beijing) LLC was established in 2019, dedicated to the research, development and sales of pet medical drugs, pharmaceutical extras, pet medical devices, etc., and endeavours to apply the world's cutting-edge technology to the health and welfare of pets. We strictly control the raw materials, continuously research and develop, and pursue high quality products, which are exported to Japan, South Korea, the United States, Europe, Southeast Asia and other regions, in addition to the markets of mainland China, Taiwan, Hong Kong and so on.The company has the exclusive right to use the Austrian patented ingredient AKACID in the global pet market. akacid was developed and patented in Austria and clinically licensed through clinical trials, and has been officially marketed in the European Union since 2002. Its unique bactericidal and antibacterial function soon became the focus of attention, through the Vienna Medical University of basic research and hospital practice proved that akacid in the bactericidal disinfection has a breakthrough significance, is an innovative technology, can avoid the traditional chlorine, benzene, phenol, mercury and other disinfectants can not overcome the toxicity of the side effects of the whole age of people, animals, skin, eye, non-irritating, non-corrosive and drug resistance, and the high efficiency of sterilization at the same time more healthy and resistant. In addition to efficient sterilisation, it is also healthier, safer and better for the ecological environment. The Austrian Society of Hygiene, Microbiology and Preventive Medicine awarded akacid the Medal of Honour for Hygiene in 2006 in recognition of its outstanding contribution to the maintenance of a high standard of hygiene and sanitation in a rapid and sustainable manner.
